ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï´Ù?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
| ±¸ºÐ | ºÐ·ù | Ç׸ñ | °¡°ÝÁ¤º¸ (´ÜÀ§ : ¿ø) | ƯÀÌ»çÇ× | ÃÖÁ¾º¯°æÀÏ | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ¸íĪ | ÄÚµå | ±¸ºÐ | ºñ¿ë | ÃÖÀúºñ¿ë | ÃÖ´ëºñ¿ë | Ä¡·áÀç·á´ë Æ÷ÇÔ¿©ºÎ |
¾àÁ¦ºñ Æ÷ÇÔ¿©ºÎ |
||||
| °Ë»ç·á | °¨¿°Áõ Ç÷û°Ë»ç | Anti-Gliadin, IgG | NPIS0003 | 273,140 | 2023-01-07 | ||||||
| °Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti-NMO, IgG | CZ422 | 129,800 | 2025-03-13 | ||||||
| °Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti-heparin/PF4 (HIT-IgG Ab)(±¹¿ÜÀ§Å¹) | NPIS0003 | 105,250 | 2025-02-03 | ||||||
| °Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | BRCA1 À¯ÀüÀÚ, ¿¢¼Õ°á½Ç/Áߺ¹(Hereditary breast and ovarian cancer) | CZ581 | 535,350 | 2025-03-11 | ||||||
| °Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | BRCA2 À¯ÀüÀÚ, ¿¢¼Õ°á½Ç/Áߺ¹(Hereditary breast and ovarian cancer) | CZ581 | 535,350 | 2025-03-11 | ||||||
| °Ë»ç·á | ÁöÁú, ¿µ¾ç °ü·Ã°Ë»ç | Beta-carotene | NPIS0003 | 299,550 | 2022-01-11 | ||||||
| °Ë»ç·á | Ç÷¾×Çа˻ç | Blocking antibody test | 31,800 | 2017-04-24 | |||||||
| Ä¡°úóġ,¼ö¼ú·á | ±¸°¿Ü°ú ¼ö¼ú | Bone Graft[1Ä¡´ç] | NPIS0003 | 200,000 | Ãּұݾ×À¸·Î »óÅ¿¡ µû¶ó º¯°æ°¡´É | 2017-01-01 | |||||
| MRI | Ư¼ö°Ë»ç | Brain MRI + MRA -Àӻ󿬱¸¿ë | 900,000 | 2020-02-11 | |||||||
| ÃÊÀ½ÆÄ | ¿¬Á¶Á÷ | Breast Biopsy(mass1) -Special Guiding SONO For Procedure(¥±) | EB562 | 167,000 | 2019-05-03 | ||||||
| ÃÊÀ½ÆÄ | ¿¬Á¶Á÷ | Breast Biopsy(mass2) -Special Guiding SONO For Procedure(¥±) | EB562 | 217,000 | 2019-05-03 | ||||||
| °Ë»ç·á | ½Å°æ°è±â´É°Ë»ç | C Pap titration | 500,000 | 2017-01-01 | |||||||
| °Ë»ç·á | Á¾¾çÇ¥ÁöÀÚ°Ë»ç | C-GMP | 77,000 | 2017-01-01 | |||||||
| CT | CT | C-Spine CT [Àӻ󿬱¸¿ë] | HA476 | 100,000 | 2018-10-25 | ||||||
| ÀÌÇпä¹ý·á(¹°¸®Ä¡·á·á) | ¹°¸®Ä¡·á·á | C-bar º¸Á¶±â | 30,000 | 2017-01-01 | |||||||